PET Assessment of Disease Activity and Cardiovascular Disease Risk in ANCA-associated Vasculitis

Abroad (travel likely)Recruiting

Conditions

ANCA Associated Vasculitis (AAV)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Edinburgh, Edinburgh, United Kingdom
Contact: Study coordinator (Bean Dhaun, MBChB PhD) · bean.dhaun@ed.ac.uk · 01312426777
Contact: Principal Investigator (Bean Dhaun, MBChB PhD)

Study leads

Neeraj Dhaun, MBChB PhD
Principal Investigator
University of Edinburgh

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

BDB-001 Phase III Trial in ANCA-Associated Vasculitis

ANCA Associated Vasculitis (AAV)

Abroad (travel likely)RecruitingPHASE3

Beijing, China · Beijing, China

Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases

SLE · Systemic Sclerosis · IIM

Abroad (travel likely)RecruitingEARLY_PHASE1

Lianyungang, China

CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases

SLE - Systemic Lupus Erythematosus · SSc-Systemic Sclerosis · IIM- Idiopathic Inflammatory Myopathies

Abroad (travel likely)RecruitingPHASE1

Tianjin, China

Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases

Systemic Sclerosis (SSc) · ANCA Associated Vasculitis (AAV) · Idiopathic Inflammatory Myopathy (IIM)

Abroad (travel likely)Recruiting

Hangzhou, China